{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:21:44Z","timestamp":1769124104057,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although multiple radioprotectors are currently being investigated preclinically for efficacy and safety, few studies have investigated concomitant metabolic changes. This study examines the effects of amifostine on the metabolic profiles in tissues of mice exposed to cobalt-60 total-body gamma-radiation. Global metabolomic and lipidomic changes were analyzed using ultra-performance liquid chromatography (UPLC) quadrupole time-of-flight mass spectrometry (QTOF-MS) in bone marrow, jejunum, and lung samples of amifostine-treated and saline-treated control mice. Results demonstrate that radiation exposure leads to tissue specific metabolic responses that were corrected in part by treatment with amifostine in a drug-dose dependent manner. Bone marrow exhibited robust responses to radiation and was also highly responsive to protective effects of amifostine, while jejunum and lung showed only modest changes. Treatment with amifostine at 200\u2009mg\/kg prior to irradiation seemed to impart maximum survival benefit, while the lower dose of 50\u2009mg\/kg offered only limited survival benefit. These findings show that the administration of amifostine causes metabolic shifts that would provide an overall benefit to radiation injury and underscore the utility of metabolomics and lipidomics to determine the underlying physiological mechanisms involved in the radioprotective efficacy of amifostine. This approach may be helpful in identifying biomarkers for radioprotective efficacy of amifostine and other countermeasures under development.<\/jats:p>","DOI":"10.1038\/s41598-019-52120-w","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T20:29:05Z","timestamp":1572467345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Metabolomic studies in tissues of mice treated with amifostine and exposed to gamma-radiation"],"prefix":"10.1038","volume":"9","author":[{"given":"Amrita K.","family":"Cheema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meth","family":"Jayatilake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison","family":"Simas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Y.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayodele O.","family":"Olabisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Seed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"52120_CR1","unstructured":"Hall, E. J. & Giaccia, A. J. Radiobiology for the Radiologist. 7th edn, (Lippincott Williams and Wilkins, 2012)."},{"key":"52120_CR2","unstructured":"Cerveny, T. J., MacVittie, T. M. & Young, R. W. In Medical Consequences of Nuclear Warfare, Textbook of Military Medicine Vol. 2 (eds Cerveny, T. J. & Walker, R. I.) 15\u201336 (TMM Publications, Office of the Surgeon General, 1989)."},{"key":"52120_CR3","unstructured":"Walden, T. L. In Medical Consequences of Nuclear Warfare (eds Walker, R. I. & Cerveny, T. J.) Ch. 9, 171\u2013226 (Office of Surgeon General, Department of the Army, TMM Publications, 1989)."},{"key":"52120_CR4","doi-asserted-by":"crossref","unstructured":"Devine, R. T. & Chaput, R. L. In Military Radiobiology (eds Conklin, J. J. & Walker, R. J.) Ch. 20, 379\u2013391 (Academic Press Inc, 1987).","DOI":"10.1016\/B978-0-12-184050-1.50022-4"},{"key":"52120_CR5","unstructured":"Seed, T. M., Kaspar, L. V., Fritz, T. E. & Tolle, D. V. In Carcinogenesis Vol. 10 (eds Huberman, E. & Barr, S. H.) 363\u2013379 (Raven Press, 1985)."},{"key":"52120_CR6","doi-asserted-by":"crossref","unstructured":"Young, R. W. In Military Radiobiology (eds Conklin, J. J. & Walker, R. I.) 165\u2013190 (Academic Press, 1987).","DOI":"10.1016\/B978-0-12-184050-1.50011-X"},{"key":"52120_CR7","unstructured":"Thompson, R. C. & Mahaffey, J. A. In CONF-83095-1. Office of Scientific and Technical Information, US Department of Energy (Washington, DC, 1986)."},{"key":"52120_CR8","doi-asserted-by":"crossref","unstructured":"Broerse, J. J. & MacVittie, T. J. Response of Different Species to Total Body Irradiation. (Martinus Nijhoff Publishers, 1984).","DOI":"10.1007\/978-94-009-6048-0"},{"key":"52120_CR9","first-page":"1","volume":"167","author":"TM Seed","year":"2002","unstructured":"Seed, T. M., Blakely, W. F., Knudson, G. B., Landauer, M. R. & McClain, D. E. International Conference on Low-Level Radiation Injury and Medical Countermeasures. Military Medicine 167, 1\u2013143 (2002).","journal-title":"Military Medicine"},{"key":"52120_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/bjc.1983.37","volume":"47","author":"RH Mole","year":"1983","unstructured":"Mole, R. H., Papworth, D. G. & Corp, M. J. The dose-response for x-ray induction of myeloid leukaemia in male CBA\/H mice. British journal of cancer 47, 285\u2013291 (1983).","journal-title":"British journal of cancer"},{"key":"52120_CR11","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1073\/pnas.94.6.2615","volume":"94","author":"K Yoshida","year":"1997","unstructured":"Yoshida, K., Inoue, T., Nojima, K., Hirabayashi, Y. & Sado, T. Calorie restriction reduces the incidence of myeloid leukemia induced by a single whole-body radiation in C3H\/He mice. Proc Natl Acad Sci USA 94, 2615\u20132619 (1997).","journal-title":"Proc Natl Acad Sci USA"},{"key":"52120_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1080\/09553002.2017.1332438","volume":"93","author":"VK Singh","year":"2017","unstructured":"Singh, V. K. & Seed, T. M. A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures. International journal of radiation biology 93, 851\u2013869, https:\/\/doi.org\/10.1080\/09553002.2017.1332438 (2017).","journal-title":"International journal of radiation biology"},{"key":"52120_CR13","unstructured":"Amgen Inc. Neupogen (filgrastim) injection for subcutaneous or intravenous use, http:\/\/pi.amgen.com\/united_states\/neupogen\/neupogen_pi_hcp_english.pdf (2015)."},{"key":"52120_CR14","unstructured":"Amgen Inc. Neulasta (pegfilgrastim) injection for subcutaneous use, http:\/\/pi.amgen.com\/united_states\/neulasta\/neulasta_pi_hcp_english.pdf (2015)."},{"key":"52120_CR15","unstructured":"Sanofi-Aventis U.S. LLC. LEUKINE\u00ae (sargramostim) for injection, for subcutaneous or intravenous use, https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/103362s5240lbl.pdf?utm_campaign=20180329%20MCMi&utm_medium=email&utm_source=Eloqua (2018)."},{"key":"52120_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/09553009214551081","volume":"61","author":"Y Kataoka","year":"1992","unstructured":"Kataoka, Y., Basic, I., Perrin, J. & Grdina, D. J. Antimutagenic effects of radioprotector WR-2721 against fission-spectrum neurons and 60Co gamma-rays in mice. International journal of radiation biology 61, 387\u2013392 (1992).","journal-title":"International journal of radiation biology"},{"key":"52120_CR17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/09553009214551381","volume":"61","author":"BA Carnes","year":"1992","unstructured":"Carnes, B. A. & Grdina, D. J. In vivo protection by the aminothiol WR-2721 against neutron-induced carcinogenesis. International journal of radiation biology 61, 567\u2013576 (1992).","journal-title":"International journal of radiation biology"},{"key":"52120_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0163-7258(88)90037-X","volume":"39","author":"JS Rasey","year":"1988","unstructured":"Rasey, J. S. et al. Specific protection of different normal tissues. Pharmacology & therapeutics 39, 33\u201343 (1988).","journal-title":"Pharmacology & therapeutics"},{"key":"52120_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0163-7258(88)90032-0","volume":"39","author":"D Glover","year":"1988","unstructured":"Glover, D. et al. Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy. Pharmacology & therapeutics 39, 3\u20137 (1988).","journal-title":"Pharmacology & therapeutics"},{"issue":"Suppl 6","key":"52120_CR20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1289\/ehp.97105s61473","volume":"105","author":"JF Weiss","year":"1997","unstructured":"Weiss, J. F. Pharmacologic approaches to protection against radiation-induced lethality and other damage. Environmental Health Perspectives 105(Suppl 6), 1473\u20131478 (1997).","journal-title":"Environmental Health Perspectives"},{"key":"52120_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3109\/09553002.2014.899450","volume":"90","author":"TM Seed","year":"2014","unstructured":"Seed, T. M., Inal, C. E. & Singh, V. K. Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis. International journal of radiation biology 90, 594\u2013604, https:\/\/doi.org\/10.3109\/09553002.2014.899450 (2014).","journal-title":"International journal of radiation biology"},{"key":"52120_CR22","unstructured":"Cumberland Pharmaceuticals Inc. ETHYOL- amifostine injection, powder, lyophilized, for solution, file:\/\/\/C:\/Users\/vsingh\/Downloads\/20170606_f11c0753-ef0a-4e1b-83dd-8543649df9a5.pdf (2017)."},{"key":"52120_CR23","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","volume":"18","author":"DM Brizel","year":"2000","unstructured":"Brizel, D. M. et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 18, 3339\u20133345, https:\/\/doi.org\/10.1200\/JCO.2000.18.19.3339 (2000).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"Suppl 4","key":"52120_CR24","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/S0959-8049(96)00316-4","volume":"32A","author":"LM Schuchter","year":"1996","unstructured":"Schuchter, L. M. Exploration of platinum-based dose-intensive chemotherapy strategies with amifostine (Ethyol). European journal of cancer 32A(Suppl 4), S40\u201342 (1996).","journal-title":"European journal of cancer"},{"key":"52120_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.fct.2006.01.013","volume":"44","author":"BH Ali","year":"2006","unstructured":"Ali, B. H. & Al Moundhri, M. S. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association 44, 1173\u20131183, https:\/\/doi.org\/10.1016\/j.fct.2006.01.013 (2006).","journal-title":"Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association"},{"key":"52120_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.etp.2008.09.003","volume":"61","author":"YI Chirino","year":"2009","unstructured":"Chirino, Y. I. & Pedraza-Chaverri, J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Experimental and toxicologic pathology: official journal of the Gesellschaft fur Toxikologische Pathologie 61, 223\u2013242, https:\/\/doi.org\/10.1016\/j.etp.2008.09.003 (2009).","journal-title":"Experimental and toxicologic pathology: official journal of the Gesellschaft fur Toxikologische Pathologie"},{"key":"52120_CR27","doi-asserted-by":"publisher","unstructured":"Singh, V. K. & Seed, T. M. The efficacy and safety of amifostine for the acute radiation syndrome. Expert Opin Drug Saf, 1\u201314, https:\/\/doi.org\/10.1080\/14740338.2019.1666104 (2019).","DOI":"10.1080\/14740338.2019.1666104"},{"key":"52120_CR28","doi-asserted-by":"crossref","unstructured":"Seed, T. M. Radiation protectants: current status and future prospects. Health physics 89, 531-545, 00004032-200511000-00014 [pii] (2005).","DOI":"10.1097\/01.HP.0000175153.19745.25"},{"key":"52120_CR29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/rpd\/ncw223","volume":"172","author":"VK Singh","year":"2016","unstructured":"Singh, V. K. et al. The potentiation of the radioprotective efficacy of two medical countermeasures, gamma-tocotrienol and amifostine, by a combination prophylactic modality. Radiation protection dosimetry 172, 302\u2013310, https:\/\/doi.org\/10.1093\/rpd\/ncw223 (2016).","journal-title":"Radiation protection dosimetry"},{"key":"52120_CR30","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.2217\/fon.14.175","volume":"10","author":"RM Johnke","year":"2014","unstructured":"Johnke, R. M., Sattler, J. A. & Allison, R. R. Radioprotective agents for radiation therapy: future trends. Future oncology (London, England) 10, 2345\u20132357, https:\/\/doi.org\/10.2217\/fon.14.175 (2014).","journal-title":"Future oncology (London, England)"},{"key":"52120_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10299-w","volume":"7","author":"EL Pannkuk","year":"2017","unstructured":"Pannkuk, E. L., Laiakis, E. C., Singh, V. K. & Fornace, A. J. Lipidomic signatures of nonhuman primates with radiation-induced hematopoietic syndrome. Scientific reports 7, 9777, https:\/\/doi.org\/10.1038\/s41598-017-10299-w (2017).","journal-title":"Scientific reports"},{"key":"52120_CR32","doi-asserted-by":"publisher","unstructured":"Cheema, A. K. et al. A Metabolomic and lipidomic serum signature from nonhuman primates administered with a promising radiation countermeasure, gamma-tocotrienol. International journal of molecular sciences 19, https:\/\/doi.org\/10.3390\/ijms19010079 (2017).","DOI":"10.3390\/ijms19010079"},{"key":"52120_CR33","doi-asserted-by":"publisher","first-page":"9311","DOI":"10.1074\/jbc.M111.332395","volume":"287","author":"Y Yao","year":"2012","unstructured":"Yao, Y. et al. Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity. The Journal of biological chemistry 287, 9311\u20139321, https:\/\/doi.org\/10.1074\/jbc.M111.332395 (2012).","journal-title":"The Journal of biological chemistry"},{"key":"52120_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrendo.2015.129","volume":"11","author":"CS McCoin","year":"2015","unstructured":"McCoin, C. S., Knotts, T. A. & Adams, S. H. Acylcarnitines\u2013old actors auditioning for new roles in metabolic physiology. Nat Rev Endocrinol 11, 617\u2013625, https:\/\/doi.org\/10.1038\/nrendo.2015.129 (2015).","journal-title":"Nat Rev Endocrinol"},{"key":"52120_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/biof.1166","volume":"40","author":"L Hanus","year":"2014","unstructured":"Hanus, L., Shohami, E., Bab, I. & Mechoulam, R. N-Acyl amino acids and their impact on biological processes. Biofactors 40, 381\u2013388, https:\/\/doi.org\/10.1002\/biof.1166 (2014).","journal-title":"Biofactors"},{"key":"52120_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2307\/3577821","volume":"126","author":"SB Kandasamy","year":"1991","unstructured":"Kandasamy, S. B., Hunt, W. A. & Harris, A. H. Role of neurotensin in radiation-induced hypothermia in rats. Radiat Res 126, 218\u2013222 (1991).","journal-title":"Radiat Res"},{"key":"52120_CR37","doi-asserted-by":"publisher","first-page":"e1003123","DOI":"10.1371\/journal.pcbi.1003123","volume":"9","author":"S Li","year":"2013","unstructured":"Li, S. et al. Predicting network activity from high throughput metabolomics. PLoS Comput Biol 9, e1003123, https:\/\/doi.org\/10.1371\/journal.pcbi.1003123 (2013).","journal-title":"PLoS Comput Biol"},{"key":"52120_CR38","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.tranon.2018.03.014","volume":"11","author":"B Oronsky","year":"2018","unstructured":"Oronsky, B. et al. A review of clinical radioprotection and chemoprotection for oral mucositis. Translational oncology 11, 771\u2013778, https:\/\/doi.org\/10.1016\/j.tranon.2018.03.014 (2018).","journal-title":"Translational oncology"},{"key":"52120_CR39","doi-asserted-by":"publisher","first-page":"e95968","DOI":"10.1371\/journal.pone.0095968","volume":"9","author":"J Gu","year":"2014","unstructured":"Gu, J. et al. Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trials. PloS one 9, e95968, https:\/\/doi.org\/10.1371\/journal.pone.0095968 (2014).","journal-title":"PloS one"},{"key":"52120_CR40","doi-asserted-by":"publisher","first-page":"519","DOI":"10.18388\/abp.2017_1520","volume":"64","author":"A Wasilewski","year":"2017","unstructured":"Wasilewski, A., Krajewska, U., Owczarek, K., Lewandowska, U. & Fichna, J. Fatty acid amide hydrolase (FAAH) inhibitor PF-3845 reduces viability, migration and invasiveness of human colon adenocarcinoma Colo-205 cell line: an in vitro study. Acta Biochim Pol 64, 519\u2013525, https:\/\/doi.org\/10.18388\/abp.2017_1520 (2017).","journal-title":"Acta Biochim Pol"},{"key":"52120_CR41","unstructured":"Cumberland Pharmaceuticals Inc. Ethyol\u00ae (amifostine) for Injection, https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/020221s033lbl.pdf (2017)."},{"key":"52120_CR42","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2165\/00003495-200161050-00012","volume":"61","author":"CR Culy","year":"2001","unstructured":"Culy, C. R. & Spencer, C. M. Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome. Drugs 61, 641\u2013684 (2001).","journal-title":"Drugs"},{"key":"52120_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7, 27\u201331, https:\/\/doi.org\/10.4103\/0976-0105.177703 (2016).","journal-title":"J Basic Clin Pharm"},{"key":"52120_CR44","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.bbagen.2016.01.021","volume":"1860","author":"DR Sappington","year":"2016","unstructured":"Sappington, D. R. et al. Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines. Biochimica et biophysica acta 1860, 836\u2013843, https:\/\/doi.org\/10.1016\/j.bbagen.2016.01.021 (2016).","journal-title":"Biochimica et biophysica acta"},{"key":"52120_CR45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10620-009-0780-x","volume":"55","author":"G Hepgul","year":"2010","unstructured":"Hepgul, G. et al. Preventive effect of pentoxifylline on acute radiation damage via antioxidant and anti-inflammatory pathways. Dig Dis Sci 55, 617\u2013625, https:\/\/doi.org\/10.1007\/s10620-009-0780-x (2010).","journal-title":"Dig Dis Sci"},{"key":"52120_CR46","doi-asserted-by":"publisher","first-page":"123241","DOI":"10.1155\/2013\/123241","volume":"2013","author":"A Francois","year":"2013","unstructured":"Francois, A., Milliat, F., Guipaud, O. & Benderitter, M. Inflammation and immunity in radiation damage to the gut mucosa. BioMed research international 2013, 123241, https:\/\/doi.org\/10.1155\/2013\/123241 (2013).","journal-title":"BioMed research international"},{"key":"52120_CR47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1586\/14737159.2016.1121102","volume":"16","author":"VK Singh","year":"2016","unstructured":"Singh, V. K., Newman, V. L., Romaine, P. L., Hauer-Jensen, M. & Pollard, H. B. Use of biomarkers for assessing radiation injury and efficacy of countermeasures. Expert review of molecular diagnostics 16, 65\u201381, https:\/\/doi.org\/10.1586\/14737159.2016.1121102 (2016).","journal-title":"Expert review of molecular diagnostics"},{"key":"52120_CR48","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/HP.0000000000000494","volume":"111","author":"M Xiao","year":"2016","unstructured":"Xiao, M. The role of proinflammatory cytokine interleukin-18 in radiation injury. Health physics 111, 212\u2013217, https:\/\/doi.org\/10.1097\/HP.0000000000000494 (2016).","journal-title":"Health physics"},{"key":"52120_CR49","first-page":"96","volume":"8","author":"JB Mitchell","year":"1987","unstructured":"Mitchell, J. B. & Russo, A. The role of glutathione in radiation and drug induced cytotoxicity. The British journal of cancer. Supplement 8, 96\u2013104 (1987).","journal-title":"The British journal of cancer. Supplement"},{"key":"52120_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0163-7258(90)90048-7","volume":"47","author":"EA Bump","year":"1990","unstructured":"Bump, E. A. & Brown, J. M. Role of glutathione in the radiation response of mammalian cells in vitro and in vivo. Pharmacology & therapeutics 47, 117\u2013136 (1990).","journal-title":"Pharmacology & therapeutics"},{"key":"52120_CR51","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3109\/rab.47.4.361","volume":"47","author":"L Revesz","year":"1985","unstructured":"Revesz, L. The role of endogenous thiols in intrinsic radioprotection. International journal of radiation biology and related studies in physics, chemistry, and medicine 47, 361\u2013368 (1985).","journal-title":"International journal of radiation biology and related studies in physics, chemistry, and medicine"},{"key":"52120_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-20825-1_1","volume":"231","author":"RG Pertwee","year":"2015","unstructured":"Pertwee, R. G. Endocannabinoids and Their Pharmacological Actions. Handb Exp Pharmacol 231, 1\u201337, https:\/\/doi.org\/10.1007\/978-3-319-20825-1_1 (2015).","journal-title":"Handb Exp Pharmacol"},{"key":"52120_CR53","first-page":"833","volume":"47","author":"A Gomez-Munoz","year":"1995","unstructured":"Gomez-Munoz, A. et al. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides. Mol Pharmacol 47, 833\u2013839 (1995).","journal-title":"Mol Pharmacol"},{"key":"52120_CR54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1006\/bbrc.1997.6270","volume":"232","author":"FY Xu","year":"1997","unstructured":"Xu, F. Y. & Hatch, G. M. Cytidine-5\u2032-diphosphate-1,2-diacyl-sn-glycerol import into mitochondria through mitochondrial membrane contact sites in permeabilized rat liver hepatocytes. Biochemical and biophysical research communications 232, 261\u2013265, https:\/\/doi.org\/10.1006\/bbrc.1997.6270 (1997).","journal-title":"Biochemical and biophysical research communications"},{"key":"52120_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-014-2106-3","volume":"395","author":"M Makrecka","year":"2014","unstructured":"Makrecka, M. et al. Long-chain acylcarnitine content determines the pattern of energy metabolism in cardiac mitochondria. Molecular and cellular biochemistry 395, 1\u201310, https:\/\/doi.org\/10.1007\/s11010-014-2106-3 (2014).","journal-title":"Molecular and cellular biochemistry"},{"key":"52120_CR56","doi-asserted-by":"publisher","unstructured":"Chong, J., Yamamoto, M. & Xia, J. MetaboAnalystR 2.0: From Raw Spectra to Biological Insights. Metabolites 9, https:\/\/doi.org\/10.3390\/metabo9030057 (2019).","DOI":"10.3390\/metabo9030057"},{"key":"52120_CR57","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.nut.2004.04.003","volume":"20","author":"H Karlic","year":"2004","unstructured":"Karlic, H. & Lohninger, A. Supplementation of L-carnitine in athletes: does it make sense? Nutrition 20, 709\u2013715, https:\/\/doi.org\/10.1016\/j.nut.2004.04.003 (2004).","journal-title":"Nutrition"},{"key":"52120_CR58","unstructured":"National Research Council of the National Academy of Sciences. Guide for the care and use of laboratory animals. 8th edn, (National Academies Press, 2011)."},{"key":"52120_CR59","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0969-8043(00)00052-X","volume":"52","author":"V Nagy","year":"2000","unstructured":"Nagy, V. Accuracy considerations in EPR dosimetry. Appl Radiat Isotop 52, 1039\u20131050 (2000).","journal-title":"Appl Radiat Isotop"},{"key":"52120_CR60","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nprot.2010.50","volume":"5","author":"EJ Want","year":"2010","unstructured":"Want, E. J. et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc 5, 1005\u20131018, https:\/\/doi.org\/10.1038\/nprot.2010.50 (2010).","journal-title":"Nat Protoc"},{"key":"52120_CR61","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cell.2017.04.026","volume":"169","author":"S Li","year":"2017","unstructured":"Li, S. et al. Metabolic Phenotypes of Response to Vaccination in Humans. Cell 169, 862\u2013877 e817, https:\/\/doi.org\/10.1016\/j.cell.2017.04.026 (2017).","journal-title":"Cell"},{"key":"52120_CR62","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.aaj2155","volume":"357","author":"C Sinclair","year":"2017","unstructured":"Sinclair, C. et al. mTOR regulates metabolic adaptation of APCs in the lung and controls the outcome of allergic inflammation. Science 357, 1014\u20131021, https:\/\/doi.org\/10.1126\/science.aaj2155 (2017).","journal-title":"Science"},{"key":"52120_CR63","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.redox.2018.04.011","volume":"17","author":"LG Gardinassi","year":"2018","unstructured":"Gardinassi, L. G. et al. Integrative metabolomics and transcriptomics signatures of clinical tolerance to Plasmodium vivax reveal activation of innate cell immunity and T cell signaling. Redox Biol 17, 158\u2013170, https:\/\/doi.org\/10.1016\/j.redox.2018.04.011 (2018).","journal-title":"Redox Biol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52120-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52120-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52120-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:10:12Z","timestamp":1671289812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-52120-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["52120"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-52120-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"3 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15701"}}